These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Trends in antimicrobial resistance among today's bacterial pathogens. Thornsberry C. Pharmacotherapy; 1995; 15(1 Pt 2):3S-8S. PubMed ID: 7753690 [Abstract] [Full Text] [Related]
3. Emerging trends in antimicrobial resistance in surgical infections. A review. Neu HC. Eur J Surg Suppl; 1994; (573):7-18. PubMed ID: 7524800 [Abstract] [Full Text] [Related]
4. Bacterial resistance mechanisms to beta-lactam antibiotics: assessment of management strategies. Dudley M. Pharmacotherapy; 1995; 15(1 Pt 2):9S-14S. PubMed ID: 7753692 [Abstract] [Full Text] [Related]
5. In vitro activity of ertapenem: review of recent studies. Wexler HM. J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179 [Abstract] [Full Text] [Related]
6. Beta-lactam antibiotics and beta-lactamases: two sides of a continuing story. Richmond MH. Rev Infect Dis; 1979 Jun; 1(1):30-8. PubMed ID: 400938 [Abstract] [Full Text] [Related]
7. The evolution of antibiotic production and public health problems. Mansford KR, Slocombe B. Chemioterapia; 1987 Jun; 6(3):234-40. PubMed ID: 3496977 [Abstract] [Full Text] [Related]
8. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia. Fritsche TR, Sader HS, Stilwell MG, Dowzicky MJ, Jones RN. Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563 [Abstract] [Full Text] [Related]
11. [Mechanism of action of beta-lactam antibiotics and problems concerning the development of resistance in antibacterial chemotherapy]. Semenitz E. Wien Klin Wochenschr Suppl; 1983 Jul; 142():7-11. PubMed ID: 6606272 [Abstract] [Full Text] [Related]
13. Tigecycline: first of a new class of antimicrobial agents. Rose WE, Rybak MJ. Pharmacotherapy; 2006 Aug; 26(8):1099-110. PubMed ID: 16863487 [Abstract] [Full Text] [Related]
14. Current challenges in antimicrobial chemotherapy: the impact of extended-spectrum beta-lactamases and metallo-beta-lactamases on the treatment of resistant Gram-negative pathogens. Helfand MS, Bonomo RA. Curr Opin Pharmacol; 2005 Oct; 5(5):452-8. PubMed ID: 16084766 [Abstract] [Full Text] [Related]
15. beta-Lactam resistance and beta-lactamases in bacteria of animal origin. Li XZ, Mehrotra M, Ghimire S, Adewoye L. Vet Microbiol; 2007 Apr 15; 121(3-4):197-214. PubMed ID: 17306475 [Abstract] [Full Text] [Related]
17. The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril! Thomson JM, Bonomo RA. Curr Opin Microbiol; 2005 Oct 15; 8(5):518-24. PubMed ID: 16126451 [Abstract] [Full Text] [Related]
18. Bacteriology of surgical wound infections in a tertiary care hospital in Turkey. Surucuoglu S, Gazi H, Kurutepe S, Ozkutuk N, Ozbakkaloglu B. East Afr Med J; 2005 Jul 15; 82(7):331-6. PubMed ID: 16167704 [Abstract] [Full Text] [Related]
19. Tigecycline: in-vitro performance as a predictor of clinical efficacy. Hawkey P, Finch R. Clin Microbiol Infect; 2007 Apr 15; 13(4):354-62. PubMed ID: 17359318 [Abstract] [Full Text] [Related]
20. Tigecycline: the answer to beta-lactam and fluoroquinolone resistance? Fraise AP. J Infect; 2006 Nov 15; 53(5):293-300. PubMed ID: 16876253 [Abstract] [Full Text] [Related] Page: [Next] [New Search]